ATE529745T1 - Verfahren zur bewertung des hautempfindlichkeitsniveaus durch verwendung von mit plattenepithelkarzinom zusammenhängendem antigen als indikation - Google Patents

Verfahren zur bewertung des hautempfindlichkeitsniveaus durch verwendung von mit plattenepithelkarzinom zusammenhängendem antigen als indikation

Info

Publication number
ATE529745T1
ATE529745T1 AT07739368T AT07739368T ATE529745T1 AT E529745 T1 ATE529745 T1 AT E529745T1 AT 07739368 T AT07739368 T AT 07739368T AT 07739368 T AT07739368 T AT 07739368T AT E529745 T1 ATE529745 T1 AT E529745T1
Authority
AT
Austria
Prior art keywords
squaquate
carcinoma
indication
sensitivity level
related antigen
Prior art date
Application number
AT07739368T
Other languages
English (en)
Inventor
Chika Katagiri
Jotaro Nakanishi
Toshihiko Hibino
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Application granted granted Critical
Publication of ATE529745T1 publication Critical patent/ATE529745T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT07739368T 2006-03-17 2007-03-15 Verfahren zur bewertung des hautempfindlichkeitsniveaus durch verwendung von mit plattenepithelkarzinom zusammenhängendem antigen als indikation ATE529745T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006075024 2006-03-17
PCT/JP2007/055926 WO2007108523A1 (ja) 2006-03-17 2007-03-15 扁平上皮細胞癌関連抗原を指標とする肌の感受性の程度の評価方法

Publications (1)

Publication Number Publication Date
ATE529745T1 true ATE529745T1 (de) 2011-11-15

Family

ID=38522549

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07739368T ATE529745T1 (de) 2006-03-17 2007-03-15 Verfahren zur bewertung des hautempfindlichkeitsniveaus durch verwendung von mit plattenepithelkarzinom zusammenhängendem antigen als indikation

Country Status (7)

Country Link
US (1) US20090208985A1 (de)
EP (1) EP1995595B1 (de)
CN (1) CN101405601B (de)
AT (1) ATE529745T1 (de)
ES (1) ES2375662T3 (de)
TW (1) TWI444618B (de)
WO (1) WO2007108523A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2923610B1 (fr) * 2007-11-14 2009-11-27 Galderma Res & Dev Methode non-invasive de recueil de donnees biologiques pour l'etablissement d'un diagnostic d'une pathologie cutanee.
JP5775540B2 (ja) * 2013-02-22 2015-09-09 株式会社ファンケル 皮膚の紫外線照射により負荷される紫外線ストレスの評価方法
GB201700138D0 (en) 2017-01-05 2017-02-22 Senzagen Ab Analytical methods and arrays for use in the same
WO2025142555A1 (ja) * 2023-12-28 2025-07-03 株式会社 資生堂 食物アレルギーの評価又は予知方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10221340A (ja) * 1997-02-07 1998-08-21 Advanced Sukin Res Kenkyusho:Kk 皮膚疾患の診断方法および薬効評価方法
US20040106120A1 (en) * 2000-11-30 2004-06-03 Rachid Tazi-Ahnini Diagnosis and treatment of disease
JP3863462B2 (ja) * 2002-06-24 2006-12-27 株式会社資生堂 皮膚疾患および敏感肌の検査方法ならびにその方法に利用するキット
JP2005272343A (ja) * 2004-03-24 2005-10-06 Shiseido Co Ltd 紫外線誘導アポトーシスの抑制方法
KR101286833B1 (ko) * 2005-03-18 2013-07-17 가부시키가이샤 시세이도 편평상피세포암 관련 항원을 지표로 하는 피부 성상의 평가방법

Also Published As

Publication number Publication date
CN101405601B (zh) 2014-05-14
EP1995595B1 (de) 2011-10-19
EP1995595A4 (de) 2009-06-17
CN101405601A (zh) 2009-04-08
US20090208985A1 (en) 2009-08-20
TW200804806A (en) 2008-01-16
EP1995595A1 (de) 2008-11-26
HK1130903A1 (en) 2010-01-08
ES2375662T3 (es) 2012-03-05
WO2007108523A1 (ja) 2007-09-27
TWI444618B (zh) 2014-07-11

Similar Documents

Publication Publication Date Title
ATE518007T1 (de) Verfahren und vorrichtung zur korrelierung der ebenen von biomarker-produkten mit erkrankungen
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
ATE536553T1 (de) Verfahren zum nachweis grösserer ungünstiger kardiovaskulärer und zerebrovaskulärer ereignisse
ATE511656T1 (de) Verfahren zur risikobewertung von herzeingriffen auf gdf-15-basis
IN2013CN01129A (de)
DE60332639D1 (de) Verwendung von biomarkern zum nachweis von eierstockkrebs
ATE523777T1 (de) System und verfahren zur bestimmung der analytkonzentration mittels zeitaufgelöster amperometrie
ATE548467T1 (de) Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände
ATE541216T1 (de) Fluoreszenztestverfahren
ATE492815T1 (de) Diagnostik-biomolekül(e)
DE60315715D1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
ATE468535T1 (de) Verwendung von nnmt als marker für lungenkrebs
ATE529745T1 (de) Verfahren zur bewertung des hautempfindlichkeitsniveaus durch verwendung von mit plattenepithelkarzinom zusammenhängendem antigen als indikation
ATE430936T1 (de) Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
DE602005009925D1 (de) Verfahren zur beurteilung rheumatoider arthritis durch messen von anti-ccp und serumamyloid a
ATE462803T1 (de) Kit und verfahren zum nachweis von urothelkarzinom
ATE412182T1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
WO2010000467A8 (en) Asc as a marker for lung cancer
DE602007004570D1 (de) Verwendung von Nogo-C bei der Beurteilung von Herzversagen
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
DE602004001994D1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
ATE408712T1 (de) Verfahren zur bestimmung des wiederauftretens von prostata krebs
ATE359516T1 (de) Verwendung des proteins crabp ii (cellular retinoic acid-binding protein ii) als marker für brustkrebs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties